Biotechnology: Pharmaceutical Preparations Stocks
436 biotechnology: pharmaceutical preparations stocks ranked by market capitalization, page 2 of 9. Updated October 11, 2026.
Today
+1.28%Biotechnology: Pharmaceutical Preparations stocks ranked 51–100
| # | Symbol | Company | Price | % Change | Volume | Market Cap |
|---|---|---|---|---|---|---|
| 51 | MIRM | Mirum Pharmaceuticals Inc. | 86.01 | +5.73% | 1.14M | $5.58B |
| 52 | MANE | Veradermics Incorporated | 130.90 | +3.37% | 1.11M | $5.47B |
| 53 | PTCT | PTC Therapeutics Inc. | 64.70 | +3.42% | 1.17M | $5.40B |
| 54 | COGT | Cogent Biosciences Inc. | 31.00 | +3.06% | 2.52M | $5.38B |
| 55 | GRFS | Grifols S.A. ADR | 7.46 | +0.67% | 330.56K | $5.08B |
| 56 | TVTX | Travere Therapeutics Inc. | 52.13 | +0.16% | 1.17M | $4.91B |
| 57 | DNTH | Dianthus Therapeutics Inc. | 82.37 | -0.07% | 738.86K | $4.61B |
| 58 | EWTX | Edgewise Therapeutics Inc. | 39.06 | -0.43% | 991.78K | $4.24B |
| 59 | INDV | Indivior Pharmaceuticals Inc. | 35.83 | +1.07% | 3.78M | $4.23B |
| 60 | ABCL | AbCellera Biologics Inc. | 12.55 | +4.37% | 4.68M | $4.07B |
| 61 | TNGX | Tango Therapeutics Inc. | 23.81 | +5.49% | 3.10M | $4.01B |
| 62 | TLX | Telix Pharmaceuticals Limited ADR | 11.21 | +1.82% | 311.96K | $3.81B |
| 63 | OGN | Organon & Co. | 13.81 | +0.44% | 3.26M | $3.63B |
| 64 | VKTX | Viking Therapeutics Inc. | 28.51 | +2.81% | 4.03M | $3.63B |
| 65 | LEGN | Legend Biotech Corporation ADR | 18.62 | -0.48% | 1.39M | $3.62B |
| 66 | AMLX | Amylyx Pharmaceuticals Inc. | 28.14 | +3.46% | 1.47M | $3.53B |
| 67 | XENE | Xenon Pharmaceuticals Inc. | 36.44 | +0.77% | 1.23M | $3.53B |
| 68 | IDYA | IDEAYA Biosciences Inc. | 36.11 | +0.14% | 698.92K | $3.48B |
| 69 | ACAD | ACADIA Pharmaceuticals Inc. | 19.78 | +1.02% | 1.47M | $3.41B |
| 70 | PBLS | Parabilis Medicines Inc. | 27.48 | -2.17% | 1.09M | $3.39B |
| 71 | ARQT | Arcutis Biotherapeutics Inc. | 26.58 | +8.53% | 1.73M | $3.34B |
| 72 | DYN | Dyne Therapeutics Inc. | 16.64 | +1.65% | 3.57M | $3.11B |
| 73 | RCUS | Arcus Biosciences Inc. | 24.41 | +2.43% | 795.19K | $3.07B |
| 74 | ELVN | Enliven Therapeutics Inc. | 40.98 | +0.86% | 1.00M | $3.00B |
| 75 | ZLAB | Zai Lab Limited ADR | 24.99 | +0.73% | 1.02M | $2.81B |
| 76 | PGEN | Precigen Inc. | 7.81 | +2.76% | 3.38M | $2.80B |
| 77 | MRVI | Maravai LifeSciences Holdings Inc. Class A | 7.44 | +3.19% | 2.30M | $2.76B |
| 78 | MBX | MBX Biosciences Inc. | 53.24 | -0.02% | 538.78K | $2.56B |
| 79 | NAMS | NewAmsterdam Pharma Company N.V. | 21.58 | +1.48% | 1.27M | $2.52B |
| 80 | SUPN | Supernus Pharmaceuticals Inc. | 42.67 | +1.26% | 579.13K | $2.48B |
| 81 | HCM | HUTCHMED (China) Limited ADR | 14.10 | +3.15% | 50.07K | $2.45B |
| 82 | LQDA | Liquidia Corporation | 27.38 | -2.28% | 3.57M | $2.45B |
| 83 | IRON | Disc Medicine Inc. | 62.06 | +2.12% | 675.13K | $2.38B |
| 84 | SLS | SELLAS Life Sciences Group Inc. | 11.65 | +3.46% | 4.14M | $2.35B |
| 85 | HRMY | Harmony Biosciences Holdings Inc. | 40.28 | +1.72% | 487.11K | $2.35B |
| 86 | NRIX | Nurix Therapeutics Inc. | 22.35 | +0.63% | 1.41M | $2.32B |
| 87 | IMNM | Immunome Inc. | 19.55 | +1.24% | 997.78K | $2.31B |
| 88 | PBH | Prestige Consumer Healthcare Inc. | 48.23 | +0.75% | 323.70K | $2.28B |
| 89 | BHC | Bausch Health Companies Inc. | 6.04 | 0.00% | 1.01M | $2.26B |
| 90 | AUPH | Aurinia Pharmaceuticals Inc | 16.65 | +2.65% | 849.23K | $2.22B |
| 91 | PHVS | Pharvaris N.V. | 31.10 | -0.06% | 754.99K | $2.18B |
| 92 | VERA | Vera Therapeutics Inc. Class A | 29.88 | +0.50% | 996.43K | $2.15B |
| 93 | VRDN | Viridian Therapeutics Inc. | 18.66 | +1.74% | 1.33M | $2.11B |
| 94 | PRGO | Perrigo Company plc | 15.06 | +3.86% | 4.36M | $2.08B |
| 95 | MLYS | Mineralys Therapeutics Inc. | 23.37 | +4.42% | 895.21K | $2.07B |
| 96 | SDGR | Schrodinger Inc. | 27.28 | +3.37% | 2.08M | $2.04B |
| 97 | PVLA | Palvella Therapeutics Inc. | 138.77 | +5.66% | 174.04K | $2.00B |
| 98 | LKFT | Lakefront Biotherapeutics ADR | 29.73 | +0.75% | 212.54K | $1.95B |
| 99 | XERS | Xeris Biopharma Holdings Inc. | 10.48 | +2.85% | 2.71M | $1.91B |
| 100 | AGIO | Agios Pharmaceuticals Inc. | 31.81 | -0.34% | 722.28K | $1.90B |
Explore more
Prices as of Oct 11, 10:10 AM EDT. Market data is delayed at least 15 minutes and provided for informational purposes only. Not investment advice. Full disclaimer